DENTSPLY SIRONA Inc. (XRAY)
Automate Your Wheel Strategy on XRAY
With Tiblio's Option Bot, you can configure your own wheel strategy including XRAY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol XRAY
- Rev/Share 18.4195
- Book/Share 9.8394
- PB 1.4134
- Debt/Equity 1.2724
- CurrentRatio 1.6861
- ROIC -0.1338
- MktCap 2772827600.0
- FreeCF/Share 0.6924
- PFCF 20.093
- PE -2.9191
- Debt/Assets 0.4109
- DivYield 0.046
- ROE -0.4517
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | XRAY | Morgan Stanley | Overweight | Equal Weight | -- | $14 | April 15, 2025 |
| Downgrade | XRAY | Needham | Buy | Hold | -- | -- | March 13, 2025 |
| Initiation | XRAY | Wells Fargo | -- | Equal Weight | -- | $20 | Feb. 14, 2025 |
| Downgrade | XRAY | Jefferies | Buy | Hold | $30 | $20 | Jan. 23, 2025 |
| Downgrade | XRAY | Evercore ISI | Outperform | In-line | -- | $20 | Jan. 7, 2025 |
| Initiation | XRAY | Mizuho | -- | Neutral | -- | $21 | Dec. 4, 2024 |
| Reiterated | XRAY | Needham | -- | Buy | -- | $34 | Aug. 20, 2024 |
News
DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Simon Campion - President & Chief Executive Officer Herman Cueto - Interim Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley Brandon Vazquez - William Blair David Saxon - Needham & Company Jeffrey Johnson - Baird Kevin Caliendo - UBS Michael Cherny - Leerink Partners Jonathan Block - Stifel Jason Bednar - Piper Sandler Operator Good day and thank you for standing by. Welcome to the Q4 …
Read More
XRAY Q4 Earnings & Revenues Miss Estimates, Gross Margin Down
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Negative
DENTSPLY SIRONA's fourth-quarter results showcase dismal segmental performance with declining adjusted operating income.
Read More
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year of 2024.
Read More
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Negative
XRAY is likely to have faced a tough fourth quarter with Byte's revenue loss, weak U.S. equipment demand and implant pressures.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect
Published: February 19, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Read More
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating DENTSPLY SIRONA Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on behalf of long-term stockholders following a class action complaint that was filed against Dentsply on November 26, 2024 with a Class Period from May 6, 2021 to November 6, 2024. Our investigation concerns whether the board of directors of Dentsply have breached their fiduciary duties to the company.
Read More
About DENTSPLY SIRONA Inc. (XRAY)
- IPO Date 1987-08-12
- Website https://www.dentsplysirona.com
- Industry Medical - Instruments & Supplies
- CEO Simon D. Campion
- Employees 14000